name:-0.0296311378479
name:-0.018710851669312
name:-0.004849910736084
Simon; Michael R. Patent Filings

Simon; Michael R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Simon; Michael R..The latest application filed is for "human medical prophylaxis of coronaviridae pathogenic infection by topical application of immune coronaviridae immunoglobulin a".

Company Profile
6.24.34
  • Simon; Michael R. - Ann Arbor MI
  • Simon; Michael R. - Peabody MA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Treatment of intestinal dysbiosis with immunoglobin
Grant 11,319,361 - Simon May 3, 2
2022-05-03
Human Medical Prophylaxis Of Coronaviridae Pathogenic Infection By Topical Application Of Immune Coronaviridae Immunoglobulin A
App 20210340226 - Olson; Robert Scott ;   et al.
2021-11-04
Treatment of celiac disease, C. difficile infection, food intolerance and food allergy with secretory IgA/IgM
Grant 10,912,955 - Simon February 9, 2
2021-02-09
Treatment Of Intestinal Dysbiosis With Immunoglobin
App 20200109185 - Simon; Michael R.
2020-04-09
Plasma Cell Cytokine Vehicle Containing Fusion Proteins For Targeted Introduction Of Sirna Into Cells And Tissues
App 20200022999 - Arya; Bira ;   et al.
2020-01-23
Plasma cell cytokine vehicle containing fusion proteins for targeted introduction of siRNA into cells and tissues
Grant 10,485,879 - Arya , et al. Nov
2019-11-26
PROCESS FOR PREPARATION OF SECRETORY IgA AND SECRETORY IgM
App 20190256577 - Brown; Stephen C. ;   et al.
2019-08-22
Process for preparation of secretory IgA and secretory IgM
Grant 10,385,117 - Brown , et al. A
2019-08-20
Plasma Cell Cytokine Vehicle Containing Fusion Proteins For Targeted Introduction Of Sirna Into Cells And Tissues
App 20180280526 - Arya; Bira ;   et al.
2018-10-04
PROCESS FOR PREPARATION OF SECRETORY IgA AND SECRETORY IgM
App 20170058018 - Brown; Stephen C. ;   et al.
2017-03-02
TREATMENT OF CELIAC DISEASE, C. DIFFICILE INFECTION, FOOD INTOLERANCE AND FOOD ALLERGY WITH SECRETORY IgA/IgM
App 20160319039 - Simon; Michael R.
2016-11-03
Treatment of food intolerance and food allergy with IgM
Grant 9,409,996 - Simon August 9, 2
2016-08-09
TREATMENT OF FOOD INTOLERANCE AND FOOD ALLERGY WITH IgA
App 20160145353 - Simon; Michael R.
2016-05-26
Treatment of food intolerance and food allergy with IgM
Grant 9,273,129 - Simon March 1, 2
2016-03-01
Conveyor assembly and associated method
Grant 9,227,784 - Laverdiere , et al. January 5, 2
2016-01-05
Conveyor Assembly And Associated Method
App 20140367228 - Laverdiere; James ;   et al.
2014-12-18
PROCESS FOR PREPARATION OF SECRETORY IgA AND SECRETORY IgM
App 20140371431 - Brown; Stephen C. ;   et al.
2014-12-18
TREATMENT OF FOOD INTOLERANCE AND FOOD ALLERGY WITH IgA
App 20140348935 - Simon; Michael R.
2014-11-27
SYNTHETIC SINGLE CHAIN VARIABLE DOMAIN (SCFV) IMMUNOGLOBULIN FRAGMENT VEHICLE CONTAINING FUSION PROTEINS FOR TARGETED INTRODUCTION OF siRNA
App 20140234961 - Simon; Michael R. ;   et al.
2014-08-21
Treatment of celiac disease with IgA
Grant 8,709,413 - Simon April 29, 2
2014-04-29
Treatment of celiac disease with IgA
Grant 8,313,730 - Simon , et al. November 20, 2
2012-11-20
Treatment of celiac disease with IgA
Grant 8,119,104 - Simon , et al. February 21, 2
2012-02-21
Treatment of celiac disease with IgA
App 20110305753 - Simon; Michael R.
2011-12-15
Synthesis of human secretory IgA and IgM and the formation of a medicament therefrom
Grant 8,021,645 - Simon , et al. September 20, 2
2011-09-20
Composition And Method For Introduction Of Rna Interference Sequences Into Targeted Cells And Tissues
App 20110117088 - Simon; Michael R.
2011-05-19
Composition And Method For Introduction Of Rna Interference Sequences Into Targeted Cells And Tissues
App 20110110937 - Simon; Michael R.
2011-05-12
Synthesis of human secretory IgM and the treatment of clostridium difficile associated diseases herewith
Grant 7,794,721 - Simon September 14, 2
2010-09-14
Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases
Grant 7,597,891 - Simon October 6, 2
2009-10-06
SYNTHESIS OF HUMAN SECRETORY IgA AND IgM AND THE FORMATION OF A MEDICAMENT THEREFROM
App 20080260822 - Simon; Michael R. ;   et al.
2008-10-23
HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
App 20080145420 - Simon; Michael R.
2008-06-19
SYNTHESIS OF HUMAN SECRETORY IgM AND THE TREATMENT OF COLSTRIDIUM DIFFICILE ASSOCIATED DISEASES HEREWITH
App 20080145370 - Simon; Michael R.
2008-06-19
SYNTHESIS OF HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
App 20080145371 - Simon; Michael R.
2008-06-19
Composition and method for introduction of RNA interference sequences into targeted cells and tissues
App 20060030003 - Simon; Michael R.
2006-02-09
Composition and method for introduction of RNA interference sequences into targeted cells and tissues
App 20050260214 - Simon, Michael R.
2005-11-24
Human medical treatment by aerosol inhalation of immunoglobulin A
Grant 6,967,106 - Simon November 22, 2
2005-11-22
Composition and method for introduction of DNA directed RNA interference sequences into targeted cells and tissues
App 20050255120 - Simon, Michael R.
2005-11-17
Human medical treatment by aerosol inhalation of immunoglobulin A
Grant 6,932,967 - Simon August 23, 2
2005-08-23
Ocular treatment by topical application of an immunoglobulin
App 20030021778 - Simon, Michael R.
2003-01-30
Human medical treatment by aerosol inhalation of immunoglobulin A
App 20020136695 - Simon, Michael R.
2002-09-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed